SCHEMBL3356750

SCHEMBL3356750

CCc1cccc(CNCC(O)C(Cc2cc(F)cc(F)c2)NC(=O)c2cnsn2)c1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.59
CTSD P07339 3/20 0.59
CTSB P07858 15/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13306013 1.00 BACE1 (0.59) BACE1CTSDCTSB
SCHEMBL3356410 1.00 BACE1 (0.59) BACE1CTSDCTSB
SCHEMBL3356422 1.00 BACE1 (0.59) BACE1CTSDCTSB
SCHEMBL3352275 0.84 BACE1 (0.76) BACE1CTSDCTSB
SCHEMBL3350377 0.84 BACE1 (0.59) BACE1CTSDCTSB
SCHEMBL3352264 0.84 BACE1 (0.76) BACE1CTSDCTSB
SCHEMBL3350386 0.84 BACE1 (0.59) BACE1CTSDCTSB
SCHEMBL3351689 0.84 BACE1 (0.67) BACE1CTSDCTSB
SCHEMBL3351683 0.84 BACE1 (0.67) BACE1CTSDCTSB
SCHEMBL3358921 0.84 BACE1 (0.73) BACE1CTSDCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357766-A1 PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME THE BROAD INSTITUTE, INC. (US) 2023-11-09 US claimed
EP-4217490-A2 PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME The Broad Institute Inc. (US) 2023-08-02 EP claimed
US-20230357766-A1 PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME THE BROAD INSTITUTE, INC. (US) 2023-11-09 US disclosed
EP-4217490-A2 PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME The Broad Institute Inc. (US) 2023-08-02 EP disclosed
US-7727997-B2 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-20070249820-A1 Activatable Ribozymal Purification Constructs and Methods of Use THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2007-10-25 US disclosed
US-7176242-B2 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARMACEUTICALS, INC. (US) 2007-02-13 US disclosed
WO-2005067665-A2 ACTIVATABLE RIBOZYMAL PURIFICATION CONSTRUCTS AND METHODS OF USE UNIVERSITY OF COLORADO (US) 2005-07-28 WO disclosed